Actionable news
0
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Neurocrine Biosciences's Chief Financial Officer was just granted 79,200 options and restricted shares

Timothy P Coughlin, Neurocrine Biosciences's Chief Financial Officer, just received 79,200 options and restricted shares from the company. The strike prices of the options received ranged from $0.00 to $35.99, and these expire on February 05, 2026. The restricted shares don't become available to Coughlin until February 05, 2020. Coughlin now has at least 48,500 options, and at least 30,700 restricted shares.

Some additional info was provided as follows:

Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock. The Restricted...

More